Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-029269
Filing Date
2023-02-09
Accepted
2023-02-09 08:23:19
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d439520ds3.htm S-3 255336
2 EX-4.2 d439520dex42.htm EX-4.2 440428
3 EX-5.1 d439520dex51.htm EX-5.1 24555
4 EX-23.2 d439520dex232.htm EX-23.2 1710
5 EX-FILING FEES d439520dexfilingfees.htm EX-FILING FEES 30207
6 GRAPHIC g439520g0208014757712.jpg GRAPHIC 2430
7 GRAPHIC g439520g03p03.jpg GRAPHIC 593350
  Complete submission text file 0001193125-23-029269.txt   1565880
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269654 | Film No.: 23601230
SIC: 2834 Pharmaceutical Preparations